These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 33593773)

  • 21. Defining treatment-resistant depression.
    Gaynes BN; Lux L; Gartlehner G; Asher G; Forman-Hoffman V; Green J; Boland E; Weber RP; Randolph C; Bann C; Coker-Schwimmer E; Viswanathan M; Lohr KN
    Depress Anxiety; 2020 Feb; 37(2):134-145. PubMed ID: 31638723
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early improvement and response to antidepressant medications in adults with major depressive disorder. Meta-analysis and study of a sample with treatment-resistant depression.
    Olgiati P; Serretti A; Souery D; Dold M; Kasper S; Montgomery S; Zohar J; Mendlewicz J
    J Affect Disord; 2018 Feb; 227():777-786. PubMed ID: 29254066
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Depression in Adult and Youth Populations: A Systematic Literature Review and Meta-Analysis.
    Leggett LE; Soril LJ; Coward S; Lorenzetti DL; MacKean G; Clement FM
    Prim Care Companion CNS Disord; 2015; 17(6):. PubMed ID: 27057417
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Simvastatin add-on to escitalopram in patients with comorbid obesity and major depression (SIMCODE): study protocol of a multicentre, randomised, double-blind, placebo-controlled trial.
    Otte C; Chae WR; Nowacki J; Kaczmarczyk M; Piber D; Roepke S; Märschenz S; Lischewski S; Schmidt S; Ettrich B; Grabe HJ; Hegerl U; Hinkelmann K; Hofmann T; Janowitz D; Junghanns K; Kahl KG; Klein JP; Krueger THC; Leicht G; Prvulovic D; Reif A; Schoettle D; Strauss M; Westermair A; Friede T; Gold SM
    BMJ Open; 2020 Dec; 10(12):e040119. PubMed ID: 33262189
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Can Atypical Antipsychotic Augmentation Reduce Subsequent Treatment Failure More Effectively Among Depressed Patients with a Higher Degree of Treatment Resistance? A Meta-Analysis of Randomized Controlled Trials.
    Wang HR; Woo YS; Ahn HS; Ahn IM; Kim HJ; Bahk WM
    Int J Neuropsychopharmacol; 2015 Mar; 18(8):. PubMed ID: 25770098
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A meta-analysis of the potential antidepressant effects of buprenorphine versus placebo as an adjunctive pharmacotherapy for treatment-resistant depression.
    Dinoff A; Lynch ST; Sekhri N; Klepacz L
    J Affect Disord; 2020 Jun; 271():91-99. PubMed ID: 32479336
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Study protocol for a network meta-analysis of digital-technology-based psychotherapies for PTSD in adults.
    He L; Geng Y; Pan Y; Tian J; He X; Deng X; Duan W; Peng H
    BMJ Open; 2020 Dec; 10(12):e038951. PubMed ID: 33303442
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exploring the efficacy of psychological treatments for depression: a multiverse meta-analysis protocol.
    Plessen CY; Karyotaki E; Cuijpers P
    BMJ Open; 2022 Jan; 12(1):e050197. PubMed ID: 35078836
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fever control interventions versus placebo, sham or no intervention in adults: a protocol for a systematic review with meta-analysis and Trial Sequential Analysis.
    Sethi N; Naqash AI; Nielsen N; Jakobsen JC
    BMJ Open; 2019 Nov; 9(11):e032389. PubMed ID: 31685514
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacologic approaches to treatment resistant depression: Evidences and personal experience.
    Tundo A; de Filippis R; Proietti L
    World J Psychiatry; 2015 Sep; 5(3):330-41. PubMed ID: 26425446
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative efficacy and acceptability of antidepressants, psychological interventions, and their combination for depressive disorder in children and adolescents: protocol for a network meta-analysis.
    Zhou X; Cipriani A; Zhang Y; Cuijpers P; Hetrick SE; Weisz JR; Pu J; Del Giovane C; Furukawa TA; Barth J; Coghill D; Leucht S; Yang L; Ravindran AV; Xie P
    BMJ Open; 2017 Aug; 7(8):e016608. PubMed ID: 28801423
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Propofol enhancement of slow wave sleep to target the nexus of geriatric depression and cognitive dysfunction: protocol for a phase I open label trial.
    Rios RL; Green M; Smith SK; Kafashan M; Ching S; Farber NB; Lin N; Lucey BP; Reynolds CF; Lenze EJ; Palanca BJA;
    BMJ Open; 2024 May; 14(5):e087516. PubMed ID: 38816055
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment-resistant depression: definitions, review of the evidence, and algorithmic approach.
    McIntyre RS; Filteau MJ; Martin L; Patry S; Carvalho A; Cha DS; Barakat M; Miguelez M
    J Affect Disord; 2014 Mar; 156():1-7. PubMed ID: 24314926
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of Esketamine Nasal Spray Plus Oral Antidepressant Treatment for Relapse Prevention in Patients With Treatment-Resistant Depression: A Randomized Clinical Trial.
    Daly EJ; Trivedi MH; Janik A; Li H; Zhang Y; Li X; Lane R; Lim P; Duca AR; Hough D; Thase ME; Zajecka J; Winokur A; Divacka I; Fagiolini A; Cubala WJ; Bitter I; Blier P; Shelton RC; Molero P; Manji H; Drevets WC; Singh JB
    JAMA Psychiatry; 2019 Sep; 76(9):893-903. PubMed ID: 31166571
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combination therapy with monoamine oxidase inhibitors and other antidepressants or stimulants: strategies for the management of treatment-resistant depression.
    Thomas SJ; Shin M; McInnis MG; Bostwick JR
    Pharmacotherapy; 2015 Apr; 35(4):433-49. PubMed ID: 25884531
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of acute musculoskeletal pain (excluding low back pain): protocol for a systematic review and network meta-analysis of randomised trials.
    Busse JW; Craigie S; Sadeghirad B; Couban R; Hong P; Oparin Y; May C; Lok A; Guyatt GH
    BMJ Open; 2019 Apr; 9(4):e024441. PubMed ID: 30948570
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Can Machine Learning help us in dealing with treatment resistant depression? A review.
    Pigoni A; Delvecchio G; Madonna D; Bressi C; Soares J; Brambilla P
    J Affect Disord; 2019 Dec; 259():21-26. PubMed ID: 31437696
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and moderators of psychological interventions in treating subclinical symptoms of depression and preventing major depressive disorder onsets: protocol for an individual patient data meta-analysis of randomised controlled trials.
    Ebert DD; Buntrock C; Reins JA; Zimmermann J; Cuijpers P
    BMJ Open; 2018 Mar; 8(3):e018582. PubMed ID: 29549201
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Benefits and safety of transdermal glyceryl trinitrate in acute stroke: a systematic review and meta-analysis of randomised trials (protocol).
    Lim BL; Lee WF; Ng WM; Tay WL; Chan WL
    BMJ Open; 2021 Jan; 11(1):e043591. PubMed ID: 33402412
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Difference in remission in a Chinese population with anxious versus nonanxious treatment-resistant depression: a report of OPERATION study.
    Wu Z; Chen J; Yuan C; Hong W; Peng D; Zhang C; Cao L; Fang Y
    J Affect Disord; 2013 Sep; 150(3):834-9. PubMed ID: 23570952
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.